Concord Biotech announced the outcome of its Board meeting held on February 11, 2026. The Board approved the Unaudited Standalone and Consolidated Financial Results for the Third Quarter and Nine Months ended December 31, 2025, which received an unmodified opinion upon limited review. A key managerial change was also confirmed: Mr. Paritosh Trivedi was appointed as the new Company Secretary, Compliance Officer, and Nodal Officer, effective the same day.
Board Meeting Outcomes: February 11, 2026
The Board of Directors of Concord Biotech Limited met on Wednesday, February 11, 2026, to discuss and approve key operational and financial matters. The meeting commenced at 05:00 P.M. and concluded at 06:22 P.M.
Unaudited Financial Results Approval
Following review and recommendation by the Audit Committee, the Board formally approved the Unaudited Standalone and Consolidated Financial Results for the Third quarter and the Nine months ended December 31, 2025. These results were accompanied by Limited Review Reports with Unmodified Opinion issued by the Statutory Auditors, M/s. BSR & Co. LLP.
Standalone Financial Highlights (Q3 FY26 vs. Previous Periods)
Reviewing the standalone Statement of Unaudited Financial Results reveals several key movements for the Quarter Ended 31-Dec-25:
- Total Income: Stood at ₹28,774.22 lakhs, compared to ₹26,040.96 lakhs in the previous quarter (30-Sep-25).
- Total Expenses: Increased slightly to ₹19,761.40 lakhs from ₹17,701.70 lakhs (Q2 FY26).
- Profit Before Tax (PBT): Reported at ₹8,615.59 lakhs for the quarter.
- Exceptional Items: An amount of ₹327.54 lakhs was recognized under exceptional items, attributed to the statutory impact of new labour codes notified in November 2025.
- Profit After Tax (PAT): Total comprehensive income for the period attributable to owners was ₹8,745.63 lakhs.
Consolidated Financial Highlights (Nine Months Ended Dec 31, 2025)
For the nine months period ended December 31, 2025, the consolidated performance was:
- Total Income: Reached ₹76,581.70 lakhs.
- Profit After Tax (PAT) for the period: Attributable to owners was ₹17,211.54 lakhs.
- Total Comprehensive Income: Stood at ₹21,274.24 lakhs.
Appointment of Key Managerial Personnel (KMP)
The Board, based on the Nomination and Remuneration Committee’s recommendation, formally approved the appointment of Mr. Paritosh Trivedi (Membership No. A63623) as the Company Secretary, Compliance Officer, and Nodal Officer, effective from February 11, 2026. Mr. Trivedi holds an Associate Membership from the Institute of Company Secretaries of India and possesses approximately 5 years of experience in compliance and governance functions across various sectors.
Regulatory Disclosures Confirmation
The company confirmed that the required disclosures regarding deviation in proceeds, outstanding loan defaults, related party transactions, and audit qualifications were Not Applicable for this submission, as per relevant stipulations for the current filing period.
Source: BSE
